Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Hostomsky

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Oncogene|June 28, 2011
NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699J E Hunter, E Willmore, J A E Irving, et al.
Cell|October 18, 1996
The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding siteR A Love, H E Parge, J A Wickersham, et al.
Biochemistry|December 12, 1995
Structure-function analysis of the mammalian DNA polymerase beta active site: role of aspartic acid 256, arginine 254, and arginine 258 in nucleotidyl transferK L Menge, Z Hostomsky, B R Nodes, et al.
Clinical and Diagnostic Virology|September 19, 1998
The conformation of hepatitis C virus NS3 proteinase with and without NS4A: a structural basis for the activation of the enzyme by its cofactorR A Love, H E Parge, J A Wickersham, et al.
The Journal of Biological Chemistry|June 17, 1994
Subunit composition and domain structure of the Spo0A sporulation transcription factor of Bacillus subtilisJ K Grimsley, R B Tjalkens, M A Strauch, et al.
British Journal of Cancer|February 22, 2014
Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedulesJ Murray, H Thomas, P Berry, et al.
Journal of Medicinal Chemistry|November 7, 2000
Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymeraseA W White, R Almassy, A H Calvert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell linesC A Delaney, L Z Wang, S Kyle, et al.
British Journal of Cancer|October 28, 2010
Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699R A Daniel, A L Rozanska, E A Mulligan, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Oncogene|June 28, 2011
NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699J E Hunter, E Willmore, J A E Irving, et al.
Cell|October 18, 1996
The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding siteR A Love, H E Parge, J A Wickersham, et al.
Biochemistry|December 12, 1995
Structure-function analysis of the mammalian DNA polymerase beta active site: role of aspartic acid 256, arginine 254, and arginine 258 in nucleotidyl transferK L Menge, Z Hostomsky, B R Nodes, et al.
Clinical and Diagnostic Virology|September 19, 1998
The conformation of hepatitis C virus NS3 proteinase with and without NS4A: a structural basis for the activation of the enzyme by its cofactorR A Love, H E Parge, J A Wickersham, et al.
The Journal of Biological Chemistry|June 17, 1994
Subunit composition and domain structure of the Spo0A sporulation transcription factor of Bacillus subtilisJ K Grimsley, R B Tjalkens, M A Strauch, et al.
British Journal of Cancer|February 22, 2014
Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedulesJ Murray, H Thomas, P Berry, et al.
Journal of Medicinal Chemistry|November 7, 2000
Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymeraseA W White, R Almassy, A H Calvert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell linesC A Delaney, L Z Wang, S Kyle, et al.
British Journal of Cancer|October 28, 2010
Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699R A Daniel, A L Rozanska, E A Mulligan, et al.
Pageof 3